Personal tools

MCL coexpression mm9:68: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 3: Line 3:
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.180840494114715,0.762439715089559,0.711960706120658,0.956516327514853,0.791353068562827,0.127882415780397,0.101149235361393,0,0,0,0.0636076933539527,0.0558041721483835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673620022139481,0,0.125836948423969,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.056886356216389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0492938041367021,0.0598244186619439,0.0417740847988257,0.031895734489288,0.041718751492076,0.0403878614760544,0.0764305931706906,0.0480053095083702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|coexpression_dpi_cluster_scores_median=0,0,0,0,0,0,0,0.180840494114715,0.762439715089559,0.711960706120658,0.956516327514853,0.791353068562827,0.127882415780397,0.101149235361393,0,0,0,0.0636076933539527,0.0558041721483835,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0673620022139481,0,0.125836948423969,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.100004302423367,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.056886356216389,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0492938041367021,0.0598244186619439,0.0417740847988257,0.031895734489288,0.041718751492076,0.0403878614760544,0.0764305931706906,0.0480053095083702,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0
|gostat_on_MCL_coexpression=GO:0046649;lymphocyte activation;0.00156080128635091;19664,22637,50930,60533,19264,17127!GO:0002376;immune system process;0.00156080128635091;16963,22637,12394,19264,21949,17127,19664,60533,50930,16992!GO:0005164;tumor necrosis factor receptor binding;0.00156080128635091;50930,21949,16992!GO:0032813;tumor necrosis factor receptor superfamily binding;0.00156080128635091;50930,21949,16992!GO:0042110;T cell activation;0.00156080128635091;22637,50930,60533,19264,17127!GO:0045321;leukocyte activation;0.00156080128635091;19664,22637,50930,60533,19264,17127!GO:0042127;regulation of cell proliferation;0.00156080128635091;20556,19664,22637,60533,19264,17127,16992!GO:0050863;regulation of T cell activation;0.00164035057079106;22637,50930,60533,19264!GO:0001775;cell activation;0.00164035057079106;19664,22637,50930,60533,19264,17127!GO:0051249;regulation of lymphocyte activation;0.00431870052836382;22637,50930,60533,19264!GO:0050865;regulation of cell activation;0.00451145655046847;22637,50930,60533,19264!GO:0008283;cell proliferation;0.00927653768045784;20556,19664,22637,60533,19264,17127,16992!GO:0042129;regulation of T cell proliferation;0.00927653768045784;22637,60533,19264!GO:0050870;positive regulation of T cell activation;0.00927653768045784;22637,50930,19264!GO:0006955;immune response;0.00955241115460229;16963,22637,50930,19264,21949,17127,16992!GO:0048534;hemopoietic or lymphoid organ development;0.0134510631825776;19664,22637,12394,19264,16992!GO:0032944;regulation of mononuclear cell proliferation;0.0134510631825776;22637,60533,19264!GO:0050670;regulation of lymphocyte proliferation;0.0134510631825776;22637,60533,19264!GO:0042098;T cell proliferation;0.0142197735636271;22637,60533,19264!GO:0002520;immune system development;0.0154180351297486;19664,22637,12394,19264,16992!GO:0051251;positive regulation of lymphocyte activation;0.0174595076172746;22637,50930,19264!GO:0051239;regulation of multicellular organismal process;0.023099335261022;22637,50930,60533,19264,17127!GO:0032943;mononuclear cell proliferation;0.0268799056070663;22637,60533,19264!GO:0046651;lymphocyte proliferation;0.0268799056070663;22637,60533,19264!GO:0008284;positive regulation of cell proliferation;0.0304950389345426;19664,22637,19264,16992!GO:0030098;lymphocyte differentiation;0.0465363067612523;19664,22637,19264!GO:0048468;cell development;0.0466786632896314;12048,22295,12394,18566,19264,12045,19664,12633,16992!GO:0030097;hemopoiesis;0.0466786632896314;19664,22637,12394,19264!GO:0050851;antigen receptor-mediated signaling pathway;0.0466786632896314;22637,19264!GO:0042102;positive regulation of T cell proliferation;0.0466786632896314;22637,19264!GO:0005125;cytokine activity;0.0466786632896314;16963,50930,21949,16992!GO:0048522;positive regulation of cellular process;0.0466786632896314;19664,22286,22637,19264,12633,17127,16992!GO:0001915;negative regulation of T cell mediated cytotoxicity;0.0466786632896314;19264!GO:0003947;(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity;0.0466786632896314;14421!GO:0030586;[methionine synthase] reductase activity;0.0466786632896314;210009!GO:0009257;10-formyltetrahydrofolate biosynthetic process;0.0466786632896314;270685!GO:0045768;positive regulation of anti-apoptosis;0.0466786632896314;12048!GO:0032426;stereocilium bundle tip;0.0466786632896314;22295!GO:0047138;aquacobalamin reductase activity;0.0466786632896314;210009!
|gostat_on_MCL_coexpression=GO:0046649;lymphocyte activation;0.00156080128635091;19664,22637,50930,60533,19264,17127!GO:0002376;immune system process;0.00156080128635091;16963,22637,12394,19264,21949,17127,19664,60533,50930,16992!GO:0005164;tumor necrosis factor receptor binding;0.00156080128635091;50930,21949,16992!GO:0032813;tumor necrosis factor receptor superfamily binding;0.00156080128635091;50930,21949,16992!GO:0042110;T cell activation;0.00156080128635091;22637,50930,60533,19264,17127!GO:0045321;leukocyte activation;0.00156080128635091;19664,22637,50930,60533,19264,17127!GO:0042127;regulation of cell proliferation;0.00156080128635091;20556,19664,22637,60533,19264,17127,16992!GO:0050863;regulation of T cell activation;0.00164035057079106;22637,50930,60533,19264!GO:0001775;cell activation;0.00164035057079106;19664,22637,50930,60533,19264,17127!GO:0051249;regulation of lymphocyte activation;0.00431870052836382;22637,50930,60533,19264!GO:0050865;regulation of cell activation;0.00451145655046847;22637,50930,60533,19264!GO:0008283;cell proliferation;0.00927653768045784;20556,19664,22637,60533,19264,17127,16992!GO:0042129;regulation of T cell proliferation;0.00927653768045784;22637,60533,19264!GO:0050870;positive regulation of T cell activation;0.00927653768045784;22637,50930,19264!GO:0006955;immune response;0.00955241115460229;16963,22637,50930,19264,21949,17127,16992!GO:0048534;hemopoietic or lymphoid organ development;0.0134510631825776;19664,22637,12394,19264,16992!GO:0032944;regulation of mononuclear cell proliferation;0.0134510631825776;22637,60533,19264!GO:0050670;regulation of lymphocyte proliferation;0.0134510631825776;22637,60533,19264!GO:0042098;T cell proliferation;0.0142197735636271;22637,60533,19264!GO:0002520;immune system development;0.0154180351297486;19664,22637,12394,19264,16992!GO:0051251;positive regulation of lymphocyte activation;0.0174595076172746;22637,50930,19264!GO:0051239;regulation of multicellular organismal process;0.023099335261022;22637,50930,60533,19264,17127!GO:0032943;mononuclear cell proliferation;0.0268799056070663;22637,60533,19264!GO:0046651;lymphocyte proliferation;0.0268799056070663;22637,60533,19264!GO:0008284;positive regulation of cell proliferation;0.0304950389345426;19664,22637,19264,16992!GO:0030098;lymphocyte differentiation;0.0465363067612523;19664,22637,19264!GO:0048468;cell development;0.0466786632896314;12048,22295,12394,18566,19264,12045,19664,12633,16992!GO:0030097;hemopoiesis;0.0466786632896314;19664,22637,12394,19264!GO:0050851;antigen receptor-mediated signaling pathway;0.0466786632896314;22637,19264!GO:0042102;positive regulation of T cell proliferation;0.0466786632896314;22637,19264!GO:0005125;cytokine activity;0.0466786632896314;16963,50930,21949,16992!GO:0048522;positive regulation of cellular process;0.0466786632896314;19664,22286,22637,19264,12633,17127,16992!GO:0001915;negative regulation of T cell mediated cytotoxicity;0.0466786632896314;19264!GO:0003947;(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity;0.0466786632896314;14421!GO:0030586;[methionine synthase] reductase activity;0.0466786632896314;210009!GO:0009257;10-formyltetrahydrofolate biosynthetic process;0.0466786632896314;270685!GO:0045768;positive regulation of anti-apoptosis;0.0466786632896314;12048!GO:0032426;stereocilium bundle tip;0.0466786632896314;22295!GO:0047138;aquacobalamin reductase activity;0.0466786632896314;210009!
|ontology_enrichment_celltype=CL:0000791!2.36e-31!9;CL:0000789!2.36e-31!9;CL:0002420!2.36e-31!9;CL:0002419!2.36e-31!9;CL:0000790!2.36e-31!9;CL:0000838!3.16e-29!12;CL:0000624!2.97e-27!8;CL:0000893!4.92e-27!6;CL:0002489!4.92e-27!6;CL:0000898!4.92e-27!6;CL:0000809!4.92e-27!6;CL:0000810!4.92e-27!6;CL:0000895!4.92e-27!6;CL:0000808!4.92e-27!6;CL:0000894!4.92e-27!6;CL:0000806!4.92e-27!6;CL:0000807!4.92e-27!6;CL:0000805!4.92e-27!6;CL:0002425!4.92e-27!6;CL:0002436!4.92e-27!6;CL:0002427!4.92e-27!6;CL:0002428!4.92e-27!6;CL:0002429!4.92e-27!6;CL:0002433!4.92e-27!6;CL:0002431!4.92e-27!6;CL:0002432!4.92e-27!6;CL:0000542!7.02e-27!13;CL:0000051!7.02e-27!13;CL:0000084!1.81e-25!11;CL:0000827!1.81e-25!11;CL:0002242!1.35e-21!16;CL:0000738!3.00e-20!17;CL:0002087!3.00e-20!17;CL:0002031!8.46e-20!25;CL:0000988!4.50e-15!32;CL:0002032!4.50e-15!32;CL:0000037!4.50e-15!32;CL:0000566!4.50e-15!32;CL:0000837!4.50e-15!32;CL:0002320!6.29e-10!46;CL:0000134!6.29e-10!46;CL:0000219!3.49e-08!54
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002370!5.79e-34!23;UBERON:0000974!5.79e-34!23;UBERON:0004807!5.79e-34!23;UBERON:0005058!5.79e-34!23;UBERON:0003351!5.79e-34!23;UBERON:0009113!5.79e-34!23;UBERON:0003295!5.79e-34!23;UBERON:0009722!5.79e-34!23;UBERON:0005562!5.79e-34!23;UBERON:0007690!5.79e-34!23;UBERON:0006562!1.87e-32!24;UBERON:0003408!1.87e-32!24;UBERON:0001557!1.87e-32!24;UBERON:0001042!1.87e-32!24;UBERON:0008814!1.87e-32!24;UBERON:0009145!1.87e-32!24;UBERON:0000072!1.34e-28!27;UBERON:0004177!1.80e-26!29;UBERON:0005057!1.80e-26!29;UBERON:0002193!6.51e-23!48;UBERON:0002405!6.51e-23!48;UBERON:0002390!1.43e-21!45;UBERON:0003061!1.43e-21!45;UBERON:0000077!1.53e-21!35;UBERON:0000063!1.53e-21!35;UBERON:0007811!7.05e-21!36;UBERON:0000065!4.76e-18!41;UBERON:0001004!1.46e-17!42;UBERON:0000153!4.23e-17!43;UBERON:0003929!7.45e-13!55;UBERON:0002368!1.39e-11!60;UBERON:0002530!1.65e-10!65;UBERON:0000490!2.59e-10!66;UBERON:0002384!6.29e-10!46;UBERON:0003081!7.29e-10!87;UBERON:0005911!9.24e-10!69;UBERON:0000949!2.97e-09!72;UBERON:0001041!4.36e-08!80;UBERON:0000064!3.56e-07!99
}}
}}

Revision as of 21:05, 11 October 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr10:121063710..121063717,+p@chr10:121063710..121063717
+
Mm9::chr10:126582512..126582515,-p@chr10:126582512..126582515
-
Mm9::chr10:126602469..126602480,+p8@B4galnt1
Mm9::chr10:126603541..126603559,+p@chr10:126603541..126603559
+
Mm9::chr10:129768028..129768035,+p@chr10:129768028..129768035
+
Mm9::chr10:129768038..129768087,+p@chr10:129768038..129768087
+
Mm9::chr10:59842970..59842980,-p3@Cdh23
Mm9::chr10:60211980..60211986,+p@chr10:60211980..60211986
+
Mm9::chr10:6373295..6373325,-p2@Mthfd1l
Mm9::chr10:6373362..6373374,-p4@Mthfd1l
Mm9::chr10:76496049..76496060,+p4@Slc19a1
Mm9::chr10:76993304..76993316,+p@chr10:76993304..76993316
+
Mm9::chr10:88289454..88289463,-p2@Utp20
Mm9::chr11:102170573..102170589,+p@chr11:102170573..102170589
+
Mm9::chr11:102170603..102170623,+p@chr11:102170603..102170623
+
Mm9::chr11:20232573..20232606,-p3@Slc1a4
Mm9::chr11:69392626..69392642,-p7@Wrap53
Mm9::chr11:69794730..69794742,-p9@Rai12
Mm9::chr11:78787282..78787293,+p@chr11:78787282..78787293
+
Mm9::chr11:82877885..82877911,+p@chr11:82877885..82877911
+
Mm9::chr11:82878630..82878653,+p2@Slfn2
Mm9::chr11:88366060..88366068,-p@chr11:88366060..88366068
-
Mm9::chr11:97491155..97491200,+p@chr11:97491155..97491200
+
Mm9::chr12:102136674..102136710,+p@chr12:102136674..102136710
+
Mm9::chr12:109874446..109874465,+p@chr12:109874446..109874465
+
Mm9::chr12:112916305..112916351,+p1@Trmt61a
Mm9::chr12:3834789..3834813,+p@chr12:3834789..3834813
+
Mm9::chr12:3834817..3834843,+p@chr12:3834817..3834843
+
Mm9::chr12:3834850..3834864,+p@chr12:3834850..3834864
+
Mm9::chr12:3834893..3834900,+p@chr12:3834893..3834900
+
Mm9::chr12:56592475..56592485,-p@chr12:56592475..56592485
-
Mm9::chr12:85292503..85292518,-p@chr12:85292503..85292518
-
Mm9::chr13:105077113..105077142,+p@chr13:105077113..105077142
+
Mm9::chr13:105077169..105077187,+p@chr13:105077169..105077187
+
Mm9::chr13:105077437..105077459,+p3@Adamts6
Mm9::chr13:105077532..105077546,+p2@Adamts6
Mm9::chr13:105077571..105077578,+p7@Adamts6
Mm9::chr13:105077588..105077604,+p6@Adamts6
Mm9::chr13:105410279..105410284,+p@chr13:105410279..105410284
+
Mm9::chr13:30879542..30879551,-p@chr13:30879542..30879551
-
Mm9::chr13:30879995..30880017,+p@chr13:30879995..30880017
+
Mm9::chr13:30912501..30912512,-p@chr13:30912501..30912512
-
Mm9::chr13:30912528..30912538,-p@chr13:30912528..30912538
-
Mm9::chr13:30912603..30912608,-p@chr13:30912603..30912608
-
Mm9::chr13:30912611..30912629,-p@chr13:30912611..30912629
-
Mm9::chr13:68720964..68721024,-p1@Mtrr
Mm9::chr14:22667666..22667678,+p2@ENSMUST00000169054
Mm9::chr14:54496363..54496388,+p@chr14:54496363..54496388
+
Mm9::chr14:54791475..54791486,+p@chr14:54791475..54791486
+
Mm9::chr14:54799199..54799205,+p@chr14:54799199..54799205
+
Mm9::chr14:54801096..54801113,+p@chr14:54801096..54801113
+
Mm9::chr14:54801159..54801186,+p1@ENSMUST00000103705
Mm9::chr14:54801191..54801223,+p1@uc007tup.1
p2@ENSMUST00000103705
Mm9::chr14:54815712..54815739,+p1@ENSMUST00000103718
Mm9::chr14:54815743..54815751,+p2@ENSMUST00000103718
Mm9::chr14:54842413..54842429,+p@chr14:54842413..54842429
+
Mm9::chr15:36368829..36368842,+p@chr15:36368829..36368842
+
Mm9::chr15:61820512..61820516,+p@chr15:61820512..61820516
+
Mm9::chr15:66630294..66630304,+p3@Tg
Mm9::chr15:66635622..66635631,-p16@Sla
Mm9::chr15:79842670..79842696,+p@chr15:79842670..79842696
+
Mm9::chr15:80403112..80403122,+p12@Grap2
Mm9::chr15:97674105..97674129,+p@chr15:97674105..97674129
+
Mm9::chr15:98860808..98860828,+p3@Tuba1c
Mm9::chr16:46010375..46010397,-p2@Plcxd2
Mm9::chr16:52032670..52032685,+p@chr16:52032670..52032685
+
Mm9::chr16:78577044..78577051,-p8@D16Ertd472e
Mm9::chr16:92058321..92058331,+p6@Mrps6
Mm9::chr16:92825850..92825886,-p@chr16:92825850..92825886
-
Mm9::chr16:93777453..93777464,+p@chr16:93777453..93777464
+
Mm9::chr16:93777486..93777510,+p@chr16:93777486..93777510
+
Mm9::chr17:21704020..21704031,+p3@Zfp948
Mm9::chr17:27022101..27022129,+p@chr17:27022101..27022129
+
Mm9::chr17:27023180..27023193,-p4@ENSMUST00000108741
Mm9::chr17:35341591..35341599,-p@chr17:35341591..35341599
-
Mm9::chr17:35341610..35341630,-p@chr17:35341610..35341630
-
Mm9::chr17:35342110..35342168,-p1@Lta
Mm9::chr17:35342250..35342262,-p3@Lta
Mm9::chr17:35357229..35357236,+p@chr17:35357229..35357236
+
Mm9::chr17:35357241..35357262,+p@chr17:35357241..35357262
+
Mm9::chr17:36135313..36135317,+p@chr17:36135313..36135317
+
Mm9::chr17:45732791..45732816,-p14@Slc29a1
Mm9::chr17:57333593..57333613,-p1@Tnfsf14
Mm9::chr17:80461916..80461925,-p11@Hnrpll
Mm9::chr17:80573148..80573155,-p@chr17:80573148..80573155
-
Mm9::chr17:84818808..84818822,-p@chr17:84818808..84818822
-
Mm9::chr18:61008516..61008554,-p2@Tcof1
Mm9::chr19:10815425..10815439,+p1@A430093F15Rik
Mm9::chr19:29441937..29441958,+p1@Cd274
Mm9::chr19:29528972..29528994,+p@chr19:29528972..29528994
+
Mm9::chr19:5638237..5638263,+p@chr19:5638237..5638263
+
Mm9::chr1:140038899..140038910,-p@chr1:140038899..140038910
-
Mm9::chr1:140072203..140072221,-p4@Ptprc
Mm9::chr1:140072230..140072237,-p8@Ptprc
Mm9::chr1:140072248..140072265,-p3@Ptprc
Mm9::chr1:162142822..162142845,-p2@Cacybp
Mm9::chr1:166865653..166865658,-p1@Xcl1
Mm9::chr1:194956395..194956451,-p1@Diexf
Mm9::chr1:194999930..194999951,+p4@A130010J15Rik
Mm9::chr1:36818600..36818618,+p3@Zap70
Mm9::chr1:36818619..36818622,+p4@Zap70
Mm9::chr1:36818638..36818688,+p1@Zap70
Mm9::chr1:58782939..58782950,+p@chr1:58782939..58782950
+
Mm9::chr1:95949134..95949150,-p1@Pdcd1
Mm9::chr1:95949154..95949164,-p2@Pdcd1
Mm9::chr2:127159776..127159791,-p@chr2:127159776..127159791
-
Mm9::chr2:152655954..152655992,-p5@Bcl2l1
Mm9::chr2:152656002..152656015,-p9@Bcl2l1
Mm9::chr2:153104393..153104431,+p@chr2:153104393..153104431
+
Mm9::chr2:26768051..26768053,+p1@ENSMUST00000083361
Mm9::chr3:106289251..106289254,-p4@2010016I18Rik
Mm9::chr3:106593047..106593058,-p4@Cd53
Mm9::chr3:106593061..106593072,-p6@Cd53
Mm9::chr3:106593093..106593104,-p7@Cd53
Mm9::chr3:106840961..106840980,-p@chr3:106840961..106840980
-
Mm9::chr3:134961897..134961904,+p@chr3:134961897..134961904
+
Mm9::chr3:135276641..135276645,-p@chr3:135276641..135276645
-
Mm9::chr3:37543741..37543745,+p@chr3:37543741..37543745
+
Mm9::chr3:37553336..37553353,+p@chr3:37553336..37553353
+
Mm9::chr3:37553399..37553427,+p@chr3:37553399..37553427
+
Mm9::chr3:37553687..37553700,+p@chr3:37553687..37553700
+
Mm9::chr3:37554940..37554949,+p@chr3:37554940..37554949
+
Mm9::chr3:68565968..68566003,+p@chr3:68565968..68566003
+
Mm9::chr3:68584346..68584356,-p@chr3:68584346..68584356
-
Mm9::chr4:119635138..119635148,-p@chr4:119635138..119635148
-
Mm9::chr4:119705140..119705152,+p@chr4:119705140..119705152
+
Mm9::chr4:133466578..133466589,-p@chr4:133466578..133466589
-
Mm9::chr4:133801432..133801448,-p3@Zfp593
Mm9::chr4:150302128..150302144,+p1@Tnfrsf9
Mm9::chr4:32463234..32463258,+p@chr4:32463234..32463258
+
Mm9::chr4:32511711..32511722,+p@chr4:32511711..32511722
+
Mm9::chr4:32511728..32511749,+p@chr4:32511728..32511749
+
Mm9::chr4:32513661..32513674,+p@chr4:32513661..32513674
+
Mm9::chr4:32744082..32744141,+p1@Mdn1
Mm9::chr4:63521957..63521980,-p@chr4:63521957..63521980
-
Mm9::chr4:63522134..63522156,-p2@Tnfsf8
Mm9::chr5:108154953..108154960,+p4@ENSMUST00000162148
p4@uc008ymz.1
Mm9::chr5:108155161..108155187,+p1@ENSMUST00000162148
p1@uc008ymz.1
Mm9::chr5:53981578..53981590,+p4@Rbpj
Mm9::chr5:8798644..8798654,+p@chr5:8798644..8798654
+
Mm9::chr5:8798677..8798684,+p@chr5:8798677..8798684
+
Mm9::chr6:115531116..115531127,+p@chr6:115531116..115531127
+
Mm9::chr6:124679998..124680009,-p@chr6:124679998..124680009
-
Mm9::chr6:125187767..125187788,+p@chr6:125187767..125187788
+
Mm9::chr6:125215576..125215603,+p1@4930417O13Rik
Mm9::chr6:125215605..125215616,+p3@4930417O13Rik
Mm9::chr6:125216258..125216270,+p@chr6:125216258..125216270
+
Mm9::chr6:125216281..125216301,+p@chr6:125216281..125216301
+
Mm9::chr6:129132696..129132707,+p@chr6:129132696..129132707
+
Mm9::chr6:129132720..129132743,+p@chr6:129132720..129132743
+
Mm9::chr6:129188439..129188447,+p@chr6:129188439..129188447
+
Mm9::chr6:129234428..129234445,-p@chr6:129234428..129234445
-
Mm9::chr6:145023859..145023862,+p@chr6:145023859..145023862
+
Mm9::chr6:145023918..145023936,+p@chr6:145023918..145023936
+
Mm9::chr6:48689005..48689018,+p2@Gimap1
Mm9::chr6:81915659..81915673,-p2@Mrpl19
Mm9::chr6:85382005..85382039,+p2@Smyd5
Mm9::chr7:133709863..133709868,-p2@Eif3c
Mm9::chr7:134006086..134006100,+p11@Hirip3
Mm9::chr7:134006101..134006125,+p9@Hirip3
Mm9::chr7:134288065..134288079,-p@chr7:134288065..134288079
-
Mm9::chr7:147129867..147129874,+p5@Utf1
Mm9::chr7:150943007..150943022,+p@chr7:150943007..150943022
+
Mm9::chr7:52703236..52703248,+p4@Gys1
Mm9::chr7:52703256..52703264,+p7@Gys1
Mm9::chr7:52703266..52703277,+p5@Gys1
Mm9::chr7:52963182..52963199,+p9@Dbp
Mm9::chr7:97279725..97279753,-p@chr7:97279725..97279753
-
Mm9::chr8:119468224..119468230,-p@chr8:119468224..119468230
-
Mm9::chr8:119468273..119468284,-p@chr8:119468273..119468284
-
Mm9::chr8:81552528..81552553,+p6@Zfp827
Mm9::chr8:84293968..84293987,+p@chr8:84293968..84293987
+
Mm9::chr8:84294470..84294475,+p19@Inpp4b
Mm9::chr8:84347023..84347072,-p@chr8:84347023..84347072
-
Mm9::chr8:86097350..86097364,-p5@Tecr
Mm9::chr8:86097400..86097411,-p7@Tecr
Mm9::chr9:103267112..103267175,-p9@Cdv3
Mm9::chr9:120001224..120001239,+p1@Ccr8
Mm9::chr9:122908294..122908299,+p@chr9:122908294..122908299
+
Mm9::chr9:122908312..122908339,+p@chr9:122908312..122908339
+
Mm9::chr9:122908568..122908574,+p@chr9:122908568..122908574
+
Mm9::chr9:122908583..122908605,+p@chr9:122908583..122908605
+
Mm9::chr9:122930533..122930581,-p@chr9:122930533..122930581
-
Mm9::chr9:40242614..40242646,-p@chr9:40242614..40242646
-
Mm9::chr9:40242741..40242756,-p@chr9:40242741..40242756
-
Mm9::chr9:40257950..40257996,+p@chr9:40257950..40257996
+
Mm9::chr9:40262927..40262969,-p@chr9:40262927..40262969
-
Mm9::chr9:40263003..40263020,-p@chr9:40263003..40263020
-
Mm9::chr9:40263028..40263041,-p@chr9:40263028..40263041
-
Mm9::chr9:40263091..40263105,-p@chr9:40263091..40263105
-
Mm9::chr9:63559790..63559801,-p14@Smad3
Mm9::chr9:77161528..77161532,+p@chr9:77161528..77161532
+
Mm9::chr9:89094135..89094148,+p1@Bcl2a1b
Mm9::chr9:89094157..89094170,+p2@Bcl2a1b
p2@Mthfs
Mm9::chrX:104451043..104451053,+p4@Gpr174
Mm9::chrX:104451111..104451121,+p7@Gpr174
Mm9::chrX:104451495..104451506,+p3@Gpr174
Mm9::chrX:104451511..104451512,+p12@Gpr174
Mm9::chrX:54453687..54453696,+p4@Gm14718
Mm9::chrX:54453709..54453723,+p2@Gm14718
Mm9::chrX:54453734..54453748,+p3@Gm14718
Mm9::chrX:54453790..54453810,+p1@Gm14718
Mm9::chrX:79068215..79068229,-p1@ENSMUST00000118948
p1@ENSMUST00000168371


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data

GO IDGO nameFDR corrected p-value
GO:0046649lymphocyte activation0.00156080128635091
GO:0002376immune system process0.00156080128635091
GO:0005164tumor necrosis factor receptor binding0.00156080128635091
GO:0032813tumor necrosis factor receptor superfamily binding0.00156080128635091
GO:0042110T cell activation0.00156080128635091
GO:0045321leukocyte activation0.00156080128635091
GO:0042127regulation of cell proliferation0.00156080128635091
GO:0050863regulation of T cell activation0.00164035057079106
GO:0001775cell activation0.00164035057079106
GO:0051249regulation of lymphocyte activation0.00431870052836382
GO:0050865regulation of cell activation0.00451145655046847
GO:0008283cell proliferation0.00927653768045784
GO:0042129regulation of T cell proliferation0.00927653768045784
GO:0050870positive regulation of T cell activation0.00927653768045784
GO:0006955immune response0.00955241115460229
GO:0048534hemopoietic or lymphoid organ development0.0134510631825776
GO:0032944regulation of mononuclear cell proliferation0.0134510631825776
GO:0050670regulation of lymphocyte proliferation0.0134510631825776
GO:0042098T cell proliferation0.0142197735636271
GO:0002520immune system development0.0154180351297486
GO:0051251positive regulation of lymphocyte activation0.0174595076172746
GO:0051239regulation of multicellular organismal process0.023099335261022
GO:0032943mononuclear cell proliferation0.0268799056070663
GO:0046651lymphocyte proliferation0.0268799056070663
GO:0008284positive regulation of cell proliferation0.0304950389345426
GO:0030098lymphocyte differentiation0.0465363067612523
GO:0048468cell development0.0466786632896314
GO:0030097hemopoiesis0.0466786632896314
GO:0050851antigen receptor-mediated signaling pathway0.0466786632896314
GO:0042102positive regulation of T cell proliferation0.0466786632896314
GO:0005125cytokine activity0.0466786632896314
GO:0048522positive regulation of cellular process0.0466786632896314
GO:0001915negative regulation of T cell mediated cytotoxicity0.0466786632896314
GO:0003947(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity0.0466786632896314
GO:0030586[methionine synthase] reductase activity0.0466786632896314
GO:000925710-formyltetrahydrofolate biosynthetic process0.0466786632896314
GO:0045768positive regulation of anti-apoptosis0.0466786632896314
GO:0032426stereocilium bundle tip0.0466786632896314
GO:0047138aquacobalamin reductase activity0.0466786632896314



Relative expression of the co-expression cluster over median <br>Analyst:




Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>

Cell Type
Ontology termp-valuen
mature alpha-beta T cell2.36e-319
alpha-beta T cell2.36e-319
immature T cell2.36e-319
mature T cell2.36e-319
immature alpha-beta T cell2.36e-319
lymphoid lineage restricted progenitor cell3.16e-2912
CD4-positive, alpha-beta T cell2.97e-278
thymocyte4.92e-276
double negative thymocyte4.92e-276
naive T cell4.92e-276
double-positive, alpha-beta thymocyte4.92e-276
CD4-positive, alpha-beta thymocyte4.92e-276
naive thymus-derived CD4-positive, alpha-beta T cell4.92e-276
DN4 thymocyte4.92e-276
DN1 thymic pro-T cell4.92e-276
DN2 thymocyte4.92e-276
DN3 thymocyte4.92e-276
immature single positive thymocyte4.92e-276
early T lineage precursor4.92e-276
mature CD4 single-positive thymocyte4.92e-276
resting double-positive thymocyte4.92e-276
double-positive blast4.92e-276
CD69-positive double-positive thymocyte4.92e-276
CD69-positive, CD4-positive single-positive thymocyte4.92e-276
CD4-positive, CD8-intermediate double-positive thymocyte4.92e-276
CD24-positive, CD4 single-positive thymocyte4.92e-276
lymphocyte7.02e-2713
common lymphoid progenitor7.02e-2713
T cell1.81e-2511
pro-T cell1.81e-2511
nucleate cell1.35e-2116
leukocyte3.00e-2017
nongranular leukocyte3.00e-2017
hematopoietic lineage restricted progenitor cell8.46e-2025
hematopoietic cell4.50e-1532
hematopoietic oligopotent progenitor cell4.50e-1532
hematopoietic stem cell4.50e-1532
angioblastic mesenchymal cell4.50e-1532
hematopoietic multipotent progenitor cell4.50e-1532
connective tissue cell6.29e-1046
mesenchymal cell6.29e-1046
motile cell3.49e-0854

Uber Anatomy
Ontology termp-valuen
thymus5.79e-3423
neck5.79e-3423
respiratory system epithelium5.79e-3423
hemolymphoid system gland5.79e-3423
pharyngeal epithelium5.79e-3423
thymic region5.79e-3423
pharyngeal gland5.79e-3423
entire pharyngeal arch endoderm5.79e-3423
thymus primordium5.79e-3423
early pharyngeal endoderm5.79e-3423
pharynx1.87e-3224
gland of gut1.87e-3224
upper respiratory tract1.87e-3224
chordate pharynx1.87e-3224
pharyngeal arch system1.87e-3224
pharyngeal region of foregut1.87e-3224
segment of respiratory tract1.34e-2827
hemopoietic organ1.80e-2629
immune organ1.80e-2629
hemolymphoid system6.51e-2348
immune system6.51e-2348
hematopoietic system1.43e-2145
blood island1.43e-2145
mixed endoderm/mesoderm-derived structure1.53e-2135
organ segment1.53e-2135
craniocervical region7.05e-2136
respiratory tract4.76e-1841
respiratory system1.46e-1742
anterior region of body4.23e-1743
gut epithelium7.45e-1355
endocrine gland1.39e-1160
gland1.65e-1065
unilaminar epithelium2.59e-1066
connective tissue6.29e-1046
lateral plate mesoderm7.29e-1087
endo-epithelium9.24e-1069
endocrine system2.97e-0972
foregut4.36e-0880
organ part3.56e-0799


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data

Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}

Retrieved from "http://f5-webapp4.gsc.riken.jp/resource_browser/index.php?title=MCL_coexpression_mm9:68&oldid=2156479"